Summary. Pregnant gilts (3/group) were given no treatment, 10 
pregnancy in intact sows and data from sows with altered utero-ovarian relationships demon¬ strate that a common stimulus for luteolysis and relaxin release, in which prostaglandins are involved, must reach the ovaries by a systemic route (Sherwood, Chang, Bevier & Dziuk, 1975; Sherwood, Chang, Bevier, Diehl & Dziuk, 1976; Sherwood, Martin, Chang & Dziuk, 1977; Sherwood, Wilson, Edgerton & Chang, 1978; Sherwood et al, 1979) . Release of prolactin from the hypophysis might be triggered by the same stimulus (Taverne, 1979 From Day 110 of pregnancy (= start of the experiments), blood samples (10 ml) were taken at 6-h intervals (05:00, 11:00, 17:00 and 23:00 h) immediately before each experimental treat¬ ment. Blood sampling stopped within 24 h after completion of parturition. The duration of labour and the numbers of live and stillborn piglets were noted.
Blood samples were centrifuged immediately and the plasma was stored at -20°C in two separate portions (one for the relaxin determination, the other for prolactin, progesterone and oestradiol-17ß determination).
Hormone analysis
Prolactin. Plasma prolactin concentrations were measured by a specific, sensitive and homologous double-antibody radioimmunoassay, using a highly purified porcine prolactin preparation (PRL A-7). Details of the purification of prolactin, the antibody production and the assay procedure are given by Bevers, Willemse & Kruip (1978) and can be summarized as follows: antibody, raised in rabbits to the prolactin A-7 preparation, was used in a dilution of 1:10 000, which resulted in about 50% binding of the radioiodinated (according to Greenwood, Hunter & Glover (1963) with slight modifications) PRL A-7. A standard curve of 0-1-5-0 ng PRL A-7 in triplicate was employed routinely in each assay. Plasma samples were assayed at three different dilutions. Samples with a relative binding of <10% or >90% or samples which differed by more than 10% from the average of the 3 determinations were discarded and reassayed. The sensitivity of the assay was 0-4 ng/ml plasma. The intra-assay coefficient of variation was 1-8% for the intercept 46-1% bound, 5-3%at 12-8% relative binding and 3-l%at 88-1% relative binding (n = 10). The interassay coefficient of variation, assessed by replicate measurement of the same plasma sample within separate assays, was 15-1% (n = 20). The recovery percentage of 10-50 ng PRL A-7, added to the plasma from sows in the post-weaning period, was 99-12 ± 5-47% (mean + s.d., = 50). Cross-reaction with porcine LH, FSH, ACTH and GH was <0-01%, while the cross-reaction with the SP 162C (NIAMDD) porcine prolactin preparation was 36%.
Relaxin. The radioimmunoassay was performed essentially by the method of Bryant- Greenwood (1977) . Porcine relaxin was prepared from frozen ovaries of pregnant sows by extraction and purification according to the method of Sherwood & O'Byrne (1974) . Highly purified relaxin (CMy) was eluted from CM-cellulose at a position close to that of the CM-B relaxin of Sherwood & O'Byrne (1974) . It has an activity of 2000-3000 G.P.U./mg in the mouse pubic symphysis bioassay of Steinetz et al (1960) .
The antiserum used was raised by injecting 1 mg partly pure (G2) relaxin intradermally into a male rabbit in saline/Freund's complete adjuvant. This was followed by further 0-5 mg injections (i.m. in 0-9%, w/v, NaCl) at 2-3-week intervals for 2 months. Several months later 3 booster injections were given at fortnightly intervals and the rabbit was bled out 1 month after the last injection under pentobarbitone sodium anaesthesia. The serum was stored in 1 ml sealed ampoules and at 1/50 dilution in aliquots of assay buffer, all at -20°C. The final dilution used in the assay was between 1:30 000 and 1:50 000 depending on the radioactive relaxin preparation.
The CMy relaxin was iodinated by the method of Bolton & Hunter (1973) (Bolton & Hunter, 1973 ) the 125I-labelled relaxin solution was purified further 1-2 days before use. Some (1-5 ml) of the 125I-labelled relaxin solution was layered onto a 20 1-0 cm column of Sephadex G50 superfine equilibrated with 0-05 M-barbitone buffer, pH 8-5, contain¬ ing 10 mg BSA/ml, and eluted with the same buffer. Three peaks were obtained of which the middle peak (equivalent to the G2-relaxin position) was highly pure I25I-labelled relaxin. This peak was diluted further as required for use in the radioimmunoassay. The specific activities of the iodinated relaxin were in the range of 5-10 \idl\ig.
The assay buffer was 0-05 M-sodium barbitone, pH 8-5, containing 50% inactivated horse serum (Wellcome Reagents, London, U.K.) to minimize differences in protein concentration between some samples. Plasma samples were diluted into an equal volume of barbitone buffer as their first dilution. They were assayed in triplicate at 4 or 6 different dilutions. Solutions of standard and unknowns (0-2 ml) were incubated with 0-05 ml antiserum diluted in barbitone buffer for 22-24 h at 4°C. Then 0-05 ml 125I-labelled relaxin solution was added to each tube and the incubation was continued for a further 22-24 h at 4°C. Bound and free 125I-labelled relaxin were separated by double-antibody precipitation using an anti-rabbit -globulin antiserum raised in sheep: 0-05 ml normal rabbit serum (Wellcome Reagents; 1:80 dilution) and 0-1 ml double-antibody solution (1:20 dilution), both in barbitone buffer, were added to each assay tube. Incubation was continued for 16-18 h when all tubes were centrifuged for 40 min at 2000 g, 4°C. In each assay 6-12 tubes were run with no sample but with the usual amount of antiserum to determine maximum binding (45%) and 6-12 tubes were run with no sample and with 0-05 ml barbitone buffer instead of antiserum to determine the assay blank, which was 2-3%. A standard curve of 15-1800 pg CMy relaxin per tube in triplicate was employed routinely in each assay. Cross-reactivity was 100% with CMa' relaxin (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) Steroids. Progesterone levels were estimated by radioimmunoassay similar to the method described by Dieleman & Schoenmakers (1979) . The antiserum S74 12 against an 11a-hydroxyprogesterone-hemisuccinate-BSA conjugate was raised in sheep. Oestradiol-17ß levels were estimated by a radioimmunoassay largely similar to the procedure for oestrone as described by Dieleman & Schoenmakers (1979) . The antiserum OR-500 against an oestradiol-17ß-6-ketooxime-BSA conjugate was raised in sheep and generously supplied by Dr R. J. Scaramuzzi (Scaramuzzi, Corker, Young & Baird, 1975 The specificity of the antisera was expressed as the percentage cross-reaction. For the progesterone assay the main cross-reactions were: 1-35% for 17a-hydroxyprogesterone, 1-90% for 20ß-dihydroprogesterone, 77-5% for lla-hydroxyprogesterone, 23-8% for llß-hydroxyprogesterone, 0-52% for pregnenolone, 2-27% for 5a-pregnane-3ß-ol,20-one, 0-81% for corticosterone, and <0-5% for other steroids tested (Dieleman & Schoenmakers, 1979) . For the oestradiol-17ß assay cross-reactions of 2-4%, 0-22% and 0-19% were found for oestrone, oestradiol-17a and oestriol respectively and <0-1% for other steroids. The intra-and inter¬ assay coefficients of variation were 11-0 and 12-2% respectively for the progesterone assay and 8-0 and 9-6% respectively for the oestradiol-17ß assay.
Analysis of data
Because of the differences in absolute values of the individual hormone concentrations in the 3 animals of each group, it was decided not to analyse these data statistically. The individual measurements are presented in Text- fig. 1 
Results
The results are illustrated in Tables 1 and 2 Table 1 ). In contrast, the start of the prolactin and relaxin increases, and the time of the peak relaxin concentration, were not postponed, and there was an increase in the interval between these events and the expulsion of the first piglet (Table 2 ). In all 3 animals changes in prolactin concentrations were biphasic: an initial increase, coinciding with the period of increasing relaxin titres, was followed by a decrease at a time when relaxin levels had reached basal levels again (Text-fig. le) Although an increase of the prolactin concentration immediately before parturition has been reported before (van Landeghem & van de Wiel, 1978; Taverne et al., 1979; Smith & Wagner, 1980; Dusza & Krzymowska, 1981) , the present study indicates that this increase is not initiated by a decrease of the peripheral plasma progesterone concentration. On the contrary, the early onset of luteolysis in 2 of the animals that were treated with bromocriptine suggests that prolactin might be involved in the maintenance of luteal function during late gestation. An increasing density of prolactin binding sites in the luteal cells has been reported for the first half of pregnancy in the sow (Rolland, Gunsalus & Hammond, 1976) The relationship of normal changes in relaxin and progesterone concentrations to the moment of expulsion of the first piglet in the bromocriptine-treated sows together with the lack of effect of the drug on parturition is consistent with data from the cow (Schams, 1974) and sheep (Burd, Ascherman, Dowers, Scommegna & Auletta, 1978) that increasing prolactin levels are not an essential component of the mechanism of parturition. Our data appeared to be the first to indicate that reduction of the prolactin concentrations before parturition impedes the onset of lactation, although suppression of an already established lactation with bromocriptine has been reported before in sows (Smith & Wagner, 1980) . Lactation in pigs was also impeded when pigs were given porcine relaxin during an extended period in late pregnancy (Kertiles & Anderson, 1979) and when premature parturition was induced by ovariectomy (Nara, Darmadja & First, 1981) . It would be interesting to determine the changes in prolactin concen¬ tration in these experimental conditions.
The relaxin data in our study confirm the results of Sherwood et al (1975, 1978, 1979 ) who used similar experimental protocols, although in our study the peak values of relaxin occurred about 6 h earlier and appeared to be somewhat lower. Although a common stimulus may evoke the prolactin and relaxin spikes, they are independent because abolition of the prolactin spike with bromocriptine did not prevent the occurrence of a relaxin spike. Conversely, in the sows treated with progesterone there was a second prolactin spike after cessation of treatment which was not accompanied by a release of relaxin. The significance of the pre-partum relaxin spike is not clear although involvement in the softening of the cervix (Kertiles & Anderson, 1979) and in myometrial co-ordination (Downing, Bradshaw & Porter, 1980) suggest that it may be important in ensuring efficient and safe deliveries.
In several studies in which pregnancy was prolonged by exogenous progesterone (Nellor, Daniels, Hoefer, Wildt & Dukelow, 1975; Sherwood et al, 1978) or endogenous progesterone (Bosc et al, 1974 ) milk appeared in the teats at about the normal expected time of parturition, and may have been due to a rise in the plasma prolactin concentration, as observed during progesterone treatment in this study.
The persistence of high progesterone concentrations in the blood of sows after cessation of progesterone treatment was an unexpected finding in this study. One explanation is that pro¬ gesterone treatment induces the production of steroid metabolites that persist in the plasma for several days after the end of treatment and cross-react with the antiserum of our radioimmuno¬ assay. The most likely candidates for such cross-reactivity appear to be 11a-and 1 lß-hydroxyprogesterone and 5a-and 5ß-pregnane-3,20 dione and we cannot as yet eliminate this possibility. However, the need for such metabolites to persist for at least 85 h after the last progesterone injection and for at least 33 h after delivery make it unlikely. Another possibility is that sub¬ cutaneous injections of 25 mg progesterone in oil establish depots of progesterone which are only depleted very gradually. The rather fluctuating levels of progesterone in treated sows may reflect variations in the vascularization and hence absorption rates at the injection sites. Sig¬ nificantly elevated plasma progesterone concentrations have also been reported even after cessation of intramuscular injections of progesterone during late pregnancy (Gooneratne, Hartmann, McCauley & Martin, 1979) . If the latter explanation is true the high progesterone levels measured during parturition in animals from Group C suggest that progesterone may not block myometrial activity in the sow (Taverne, 1982) and its role in parturition in the pig is as problematic as it is in the ewe (Liggins, Fairclough, Grieves, Forster & Knox, 1977) .
The results obtained from the progesterone-treated animals provide additional evidence that the pre-partum prolactin spike is not dependent upon a changing progesterone/oestrogen ratio.
Indeed, both prolactin and relaxin release seemed to be triggered by a common stimulus rather than by the withdrawal of an inhibitor. The observation that final changes in the concentration of the two hormones occurred only after indomethacin treatment was ended indicates that prostaglandins are at least involved in the triggering process. A single injection of PGF-2a or its synthetic analogue, cloprostenol (Taverne, 1979) , cause an immediate release of prolactin in the late pregnant sow well before the luteolytic action of the drug becomes evident.
The results of this study are consistent with the reports that parturition in the sow is preceded by a biphasic increase of prostaglandin levels (Nara & First, 1977; Martin, 1980) . The first small rise might be responsible for the simultaneous increase of the prolactin and relaxin concen¬ trations, whereas luteolysis requires a somewhat longer period of increased PGF-2a release. The latter has been reported during luteolysis in the cyclic sow (Moeljono et al., 1977; Shille et al., 1979) . A second and larger increase of PGF-2a concentrations, close to the onset of delivery (Silver et al, 1979; First & Bosc. 1979; Martin, 1980) , might also be responsible both for the sustained rise of the prolactin values and the onset of uterine contractions either by direct stimulation of the myometrium (Taverne, 1982) and/or by provoking oxytocin release (Ellendorffera/., 1979a) .
